Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA7 | P43166 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25301790 | 1.00 | ATM (0.56) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| Hydrochloric Acid SCHEMBL7600824 | 0.98 | ATM (0.55) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| Hydrochloric Acid SCHEMBL7600821 | 0.98 | ATM (0.55) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL28009571 | 0.88 | MMP8 (0.52) | — | |
| SCHEMBL28009569 | 0.88 | MMP8 (0.52) | — | |
| SCHEMBL28209566 | 0.87 | CTSL (0.49) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL28209567 | 0.87 | CTSL (0.49) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL22557991 | 0.87 | ESR1 (0.54) | ALDH1A1 | |
| SCHEMBL93589 | 0.84 | CPA1 (0.54) | — | |
| SCHEMBL414333 | 0.84 | CPA1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107935875-A | A kind of synthetic method of melphalan | 兆科药业（广州）有限公司 | 2018-04-20 | — | — | CN | claimed |
| US-20230218710-A1 | METHOD OF TREATING CORONAVIRUS INFECTIONS | COHBAR, INC. | 2023-07-13 | — | — | US | disclosed |
| US-8961928-B2 | Ligand and metal complex having the same | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2015-02-24 | — | — | US | disclosed |
| US-20130303728-A1 | LIGAND AND METAL COMPLEX HAVING THE SAME | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2013-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303728-A1 | LIGAND AND METAL COMPLEX HAVING THE SAME | MMP12, MMEL1, PLAT | ATM 4052/4885ALDH1A1 4816/4885THRB 2440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.